Onfolio announces that its molecular hydrogen supplement subsidiary Vital Reaction successfully launched an innovative new pocket inhaler “Kencos” at the end of October. “One of the keys for growth of Vital Reaction is to launch new products, as you would expect with any eCommerce brand. Kencos has a mass appeal as an alternative to vaping or smoking for those wishing to quit. It was great to see the team at Vital Reaction, lead by Shaun Thresher, bring the product to market and have a successful launch,” said Onfolio CEO Dom Wells.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ONFO:
- Onfolio Launches Off-Market Deal Origination Service DealPipe
- Onfolio Subsidiary Vital Reaction Completes Successful Launch Of New Pocket Inahler Product
- Onfolio Web 3 subsidiary achieves first profitable month
- Onfolio Holdings Inc. Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- ONFO Upcoming Earnings Report: What to Expect?
